Business
Pharma, WHO team up to create permanent ‘pandemic’ market for mandated, experimental vaccines
From LifeSiteNews
By Brenda Baletti, Ph.D., The Defender
Unlimited Hangout journalist Max Jones details how Big Pharma is using the WHO to restructure the drug market, so inadequately tested vaccines and other drugs will face minimal regulation and entire populations can be compelled to take them each time the WHO declares another global pandemic.
Big Pharma and its key investors are rolling out a new strategy — “the full takeover of the public sector, specifically the World Health Organization (WHO), and the regulatory system that now holds the entire market hostage” — according to a new investigative report by Unlimited Hangout’s Max Jones.
What’s behind the new strategy? The pharmaceutical industry is facing a “patent cliff” by 2030, as many of its blockbuster drugs are set to lose their patent protection, placing $180 billion in sales at risk and threatening to topple the industry.
According to Jones, for years, when patents expired on profitable drugs, pharmaceutical giants deployed a “mergers and acquisitions” strategy, buying up smaller drug companies to add to their product portfolios.
As a result, the industry is now dominated by a handful of companies, conventional chemical drugs exist for most health issues, and the regulatory process for new ones has become onerous.
Big Pharma has now pivoted to acquiring biotech and biologic companies, whose products are “more complex, unpredictable and difficult and expensive to make,” than chemical-based medicine, Jones wrote.
Conventional drugs are chemically synthesized and have a known structure according to the U.S. Food and Drug Administration (FDA). Biologics come from living humans, animal or microorganism cells, and are technologically altered to target particular proteins or cells in the immune system. The FDA calls biologics “complex mixtures that are not easily identified or characterized.”
As a drug class, biologics offer an appealing solution to the patent cliff problem, because they can’t be easily replicated like generic versions of conventional drugs.
Instead, producers make “biosimilars,” which unlike genetics can’t simply be interchanged with the original drug during a course of treatment without serious safety risks, according to Jones. And while generics are cheap, biosimilars are still expensive to produce. There also are regulatory hurdles to getting biosimilars to market.
However, Jones wrote, the serious safety issues associated with biologics — the high risk of serious adverse events associated with the COVID-19 vaccine, for example — make it difficult for drugmakers to find commercial success in a conventional regulatory environment.
“Luckily for Big Pharma,” Jones wrote, the WHO and its private backers “are pursuing an unprecedented legal process that would cement loopholes that could solve these significant market challenges of at least some biotechnologies.”
Such loopholes made Pfizer and Moderna’s COVID-19 mRNA vaccines — the paradigmatic example of this new strategy — Big Pharma’s highest-selling annual market success ever.
Distribution of the COVID-19 vaccines to approximately 70% of people globally was possible only because of the “fast-tracked, deregulated development and mandated consumption of the experimental drugs,” Jones wrote.
The industry hopes to replicate that model with other drugs. And it has already begun — last month the Biomedical Advanced Research and Development Authority, or BARDA, gave Moderna $176 million to develop an mRNA bird flu vaccine.
Stakeholders behind the WHO have turned it into an arm of Big Pharma
According to Jones, the process of rapidly developed and mandated experimental drugs was first adopted by the U.S. military for bioweapons threats. Now, it is being internationally legitimized by the WHO through the agency’s revisions to the International Health Regulations (IHR) and its continued attempt to push its pandemic treaty.
The amendments were watered down and the treaty was partially thwarted at the last meeting of the World Health Assembly, which ended on June 1. However, the powers added to the amendments and the language in the treaty WHO and its backers are still hoping to advance next year show the type of biotech pandemic market Big Pharma has in the works.
According to Jones, this market:
Will not be one that depends on the free will of consumers to opt in and out of products — but instead relies on tactics of forced consumption and manipulation of regulatory paradigms.
At the forefront of this push are the WHO’s public-private-partners/private stakeholders, who directly shape and benefit from this policy. Their influence has, in effect, turned the WHO into an arm of Big Pharma, one so powerful that it already demonstrated its ability to morph the entire international regulatory process for the benefit of the pharmaceutical industry during the COVID-19 pandemic.
These stakeholders can wield this power in part because the WHO receives 80% of its funding from private stakeholders.
Those stakeholders include private-sector giants like Bill Gates, his public-private partnership organizations like the Coalition for Epidemic Preparedness Innovations (CEPI) and public-sector bureaucrats, such as Dr. Anthony Fauci and Rick Bright, Ph.D., of BARDA and the Rockefeller Foundation, who have been working for years to create a new system that would speed up vaccine production.
During the COVID-19 pandemic period, even states that lacked legal structures to provide emergency authorization for new drugs created them, using the WHO’s Emergency Use Listing Procedure (EUL) as justification, and aided by the WHO’s COVAX vaccine distribution system. COVAX was co-led by the WHO, Gavi, CEPI and Unicef, which are all backed by Gates.
The goal now, Jones wrote, is to institutionalize the procedures that were put in place globally for COVID-19 to pave the way for a new pandemic market.
The One Health agenda, which requires “full-scale surveillance of the human-animal environment,” both before and during pandemics, is central to this plan, he wrote.
The four pillars of the emerging pandemic market
There are four pillars to the plan for securing this market. The pillars are embodied in the WHO’s recently passed IHR amendments and the proposed pandemic treaty.
1. Biosurveillance of “pathogens with pandemic potential”: The WHO is calling on member states to create infrastructure to conduct biosurveillance on entire populations.
WHO private stakeholders, like the Wellcome Trust and the Bill & Melinda Gates Foundation, have been funding such initiatives for years and continue to be at the forefront of similar initiatives today, Jones wrote.
2. Rapid sharing of data and research: Under the IHR amendments, the WHO’s director-general must provide support for member states’ research and development. In the pending treaty, that would include helping them rapidly share data during a pandemic.
Such sharing should help coordinate global pandemic responses and also “pandemic prevention.” That means building a globally coordinated effort to research and share data on diseases that don’t currently pose a public health threat but are allegedly “likely to cause epidemics in the future.”
The WHO’s announcement last week that it is facilitating data-sharing for a new mRNA bird flu vaccine from Argentina is one example.
Experts have raised concerns that incentivizing such “preventive R&D” could incentivize risky gain-of-function research, Jones wrote.
Jones also noted that it is “highly likely” that the same global organizations that partner with the WHO and are funded by its largest private donors will be the ones doing this research and development on vaccines for “future pathogens with pandemic potential” — and also the ones profiting from it.
3. New regulatory pathways: The WHO is developing new regulatory pathways for unapproved medical products to get to market during pandemic emergencies. The IHR amendments are vague on this, Jones wrote, but the proposed language of the treaty aims to speed up emergency authorizations of WHO-recommended investigational “relevant health products.”
The proposed treaty also seeks to compel member countries to take steps to ensure they have the “legal, administrative and financial frameworks in place to support emergency regulatory authorizations for the effective and timely approval of pandemic-related health products during a pandemic.”
4. Global mandates of unapproved products: The final key element in the Big Pharma-WHO plan to pave the way for a new pandemic market is shoring up the global capacity to mandate unapproved medical products.
According to Jones, in July 2023, the WHO adopted the European Union’s (EU) digital COVID-19 passport system, or the “immunity pass” which recorded people’s vaccination records, negative test results or records of previous infections.
“While a digital vaccine passport does not function as a hard mandate in which every citizen of a given population is forced to take a vaccine, it acts as a conditional mandate — one which offers the illusion of choice, but — in reality — restricts the civil liberties of those who do not comply,” Jones wrote.
The 2005 version of the IHR allowed for travel-based mandates that required proof of vaccination to enter countries when there was a public health risk. The new IHR, Jones wrote, expands on this by detailing the kinds of technology that can be used to check such information during future pandemics.
The WHO also is developing its Global Digital Health Certification Network, which expands the EU digital passport system to a global scale. It will digitize vaccination records and health records and will be “interoperable” with existing networks.
While interoperability makes it possible for decentralized data to be shared globally, Jones wrote, “The UN is seeking to impose digital identification as a ‘human right,’ or rather as a condition for accessing other human rights, for the entire global citizenry by 2030, as established in its Sustainable Development Goal 16.9.”
The initiative seeks to provide people with a “trusted, verifiable way” to prove who they are in the physical world and online.
Verification systems of this size will place the right of citizens to do basic activities — like traveling, eating at a restaurant or working their job — in the hands of governments and potentially employers.
The rights of civilians will be conditional, dictated by data stored in a massive digital hub that is global in its sharing abilities. Not only will domestic governments have access to the health information of their own citizens under this system, but an entire global bureaucracy will as well.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Agriculture
Growing Alberta’s fresh food future
A new program funded by the Sustainable Canadian Agricultural Partnership will accelerate expansion in Alberta greenhouses and vertical farms.
Albertans want to keep their hard-earned money in the province and support producers by choosing locally grown, high-quality produce. The new three-year, $10-milllion Growing Greenhouses program aims to stimulate industry growth and provide fresh fruit and vegetables to Albertans throughout the year.
“Everything our ministry does is about ensuring Albertans have secure access to safe, high-quality food. We are continually working to build resilience and sustainability into our food production systems, increase opportunities for producers and processors, create jobs and feed Albertans. This new program will fund technologies that increase food production and improve energy efficiency.”
“Through this investment, we’re supporting Alberta’s growers and ensuring Canadians have access to fresh, locally-grown fruits and vegetables on grocery shelves year-round. This program strengthens local communities, drives innovation, and creates new opportunities for agricultural entrepreneurs, reinforcing Canada’s food system and economy.”
The Growing Greenhouses program supports the controlled environment agriculture sector with new construction or expansion improvements to existing greenhouses and vertical farms that produce food at a commercial scale. It also aligns with Alberta’s Buy Local initiative launched this year as consumers will be able to purchase more local produce all year-round.
The program was created in alignment with the needs identified by the greenhouse sector, with a goal to reduce seasonal import reliance entering fall, which increases fruit and vegetable prices.
“This program is a game-changer for Alberta’s greenhouse sector. By investing in expansion and innovation, we can grow more fresh produce year-round, reduce reliance on imports, and strengthen food security for Albertans. Our growers are ready to meet the demand with sustainable, locally grown vegetables and fruits, and this support ensures we can do so while creating new jobs and opportunities in communities across the province. We are very grateful to the Governments of Canada and Alberta for this investment in our sector and for working collaboratively with us.”
Sustainable Canadian Agricultural Partnership (Sustainable CAP)
Sustainable CAP is a five-year, $3.5-billion investment by federal, provincial and territorial governments to strengthen competitiveness, innovation and resiliency in Canada’s agriculture, agri-food and agri-based products sector. This includes $1 billion in federal programs and activities and $2.5 billion that is cost-shared 60 per cent federally and 40 per cent provincially/territorially for programs that are designed and delivered by provinces and territories.
Quick facts
- Alberta’s greenhouse sector ranks fourth in Canada:
- 195 greenhouses produce $145 million in produce and 60 per cent of them operate year-round.
- Greenhouse food production is growing by 6.2 per cent annually.
- Alberta imports $349 million in fresh produce annually.
- The program supports sector growth by investing in renewable and efficient energy systems, advanced lighting systems, energy-saving construction, and automation and robotics systems.
Related information
Automotive
The $50 Billion Question: EVs Never Delivered What Ottawa Promised
Beware of government promises that arrive gift-wrapped in moral certainty.
The pattern repeats across the sector: subsidies extracted, production scaled back, workers laid off, taxpayers absorbing losses while executives collect bonuses and move on, and politicians pretend that it never happened. CBC isn’t asking Justin Trudeau, Katherine McKenna or Steven Guilbeault any questions about it. They are not asking Mark Carney.
Buy an electric vehicle, they said, and you will save the planet, no questions asked. Justin Trudeau and several of his ministers proclaimed it from podiums. Environmental activists, often cabinet members, chanted it at rallies. Automotive executives leveraged it to extract giant subsidies. For over a decade, the message never wavered: until $50 billion in public money disappeared into corporate failures, and the economic wreckage became impossible to ignore.
Prime Minister Mark Carney, himself a spokesperson for the doomsday culture, inherited the policy disaster from Trudeau and still clings to the wreckage. The 2026 EV sales target sits suspended, a grudging acknowledgment that reality refused to cooperate with radical predictions and Ottawa’s mandates. Yet the 2030 and 2035 targets remain federal law, monuments to a central-planning exercise that delivered the opposite of what it promised.
Their claims were never quite true. Electric vehicles were pure good. They were marketed as unconditionally cleaner than conventional cars, a transformation so obviously beneficial that questioning it invited accusations of climate denial. Government messaging suggested switching to an EV meant immediate environmental virtue. The nuance, the conditions, and the caveats were conveniently omitted from the government sales pitch that justified tens of billions of your money into subsidies for foreign EV manufacturing and corporate advancement.
The Reality Ottawa Is Hiding
Research documented the conditional nature of EV benefits for over a decade, yet Ottawa proceeded as if the complexity didn’t exist. Studies from China, where coal dominates electricity generation, showed as early as 2010 that EVs in coal-dependent regions had “very limited benefits” in reducing emissions compared to gasoline vehicles. In Northern China, where electricity generation is over 80% coal-based, EVs could produce lifecycle emissions comparable to or even higher than those of conventional cars. A 2015 Chinese study found that EVs generated lifecycle emissions that were only 18% lower than those of gasoline vehicles, compared to 40-70% reductions in regions with cleaner grids.
Volvo began publishing transparent lifecycle assessments for its first EV in 2019, making it the first major automaker to document the significant upfront emissions from battery production publicly. Their 2021 C40 Recharge report, released during the COP26 climate summit in Glasgow, revealed that manufacturing an EV produces 70% more emissions than building a comparable conventional vehicle. But there are no CBC reports about that. The Volvo report showed that an EV charged on a coal-heavy global grid required 68,000 to 110,000 miles of driving to break even with a conventional car, potentially more than half the vehicle’s usable lifetime. For drivers with low annual mileage in regions with dirty electricity grids, that breakeven point could take six to nine years to reach, if ever.
Battery manufacturing location proved enormously consequential. Production in China, powered by coal, generates 60-85% higher emissions than manufacturing in Europe or the United States. Yet Canadian subsidies flowed to companies regardless of where batteries were made or where vehicles would be charged. The federal government committed over $50 billion without requiring the environmental due diligence that should precede such massive public investment.
The Canadian government never acknowledged Volvo’s findings. Not once. A search of federal policy documents, ministerial statements, and environmental assessments from 2019 forward reveals no mention of the lifecycle complexities Volvo documented. Ottawa’s silence on inconvenient research speaks loudly about how ideology trumped evidence in shaping EV policy.
You want to build a pipeline in Canada. There will be 8 to 10 years of red tape and environmental impact assessments. But if you say you want to make EVs, Laurentian provincial premiers and the feds will bend over backwards. They handed over billions while the economy and social conditions in their cities decayed.
The environmental promise was conditional: clean electricity grids, high annual mileage, manufacturing in regions with low-carbon energy, and vehicles driven long enough to offset the massive carbon debt from battery production. Remove those conditions, and the environmental case collapses. The subsidies, however, remained unconditional.
The Subsidies Flow, The Companies Fail
Corporate casualties now litter the landscape. Northvolt received $240 million in federal subsidies to build a Quebec battery plant before filing for bankruptcy protection in November. Lion Electric, Quebec’s homegrown EV manufacturer, burned through $100 million in government support before announcing massive layoffs and production cuts. Arrival, which secured subsidies for its electric van facility, collapsed entirely, leaving taxpayers with nothing but broken promises.
Stellantis and LG Energy Solution extracted $15 billion, the most extensive corporate handout in Canadian history, for their Windsor battery plant. Volkswagen secured $13 billion for St. Thomas. Provincial governments layered on additional incentives. The public investment dwarfed any plausible return, yet the money kept flowing based on environmental claims the government either never bothered to verify or suppressed from its own documents and reports.
Despite this flood of subsidies and regulatory coercion, Canadian consumers rejected the offering. Even with massive incentives, EVs accounted for only 15% of new vehicle sales in 2024, far short of the mandated 20% target for 2026, let alone the 60% demanded by 2030. When federal subsidies ended in early 2025, sales collapsed to 9%, revealing the limited consumer demand. Dealer lots overflow with unsold inventory. Manufacturers scaled back production plans. The market spoke; Ottawa is only half listening.
The GM plant in Oshawa serves as a cautionary tale. Thousands of jobs lost. Promises of green manufacturing jobs evaporated. Workers who believed government assurances that EV mandates would secure their livelihoods found themselves unemployed as companies redirected production or collapsed entirely. The pattern repeats across the sector: subsidies extracted, production scaled back, workers laid off, taxpayers absorbing losses while executives collect bonuses and move on, and politicians pretend that it never happened. CBC isn’t asking Justin Trudeau, Katherine McKenna or Steven Guilbeault any questions about it. They are not asking Mark Carney.
The Central Planning Failure
The EV disaster illustrates why economies run by political offices never succeed. Friedrich Hayek observed that “The curious task of economics is to demonstrate to men how little they really know about what they imagine they can design.” Politicians and bureaucrats in Ottawa do not possibly possess the dispersed knowledge embedded in millions of individual economic decisions. But they think that they do.
Markets aggregate information that no central planner can access. Consumer preferences for vehicle range, charging convenience, and total cost of ownership. Regional variations in electricity generation and the pace of grid decarbonization. Battery technology improvements and supply chain vulnerabilities. Resource constraints and mining capacity. These factors interact in ways too complex for any cabinet planning committee to comprehend, yet Ottawa presumed to mandate outcomes a generation in advance.
Federal ministers with no experience in automotive manufacturing or battery chemistry presumed to direct the transformation of a trillion-dollar industry. Career bureaucrats drafted regulations determining which vehicles Canadians could purchase years hence, as if they possessed prophetic knowledge of technological development, grid decarbonization rates, consumer preferences, and global supply chains.
The EV mandate attempted to force a technological transition. It was an economic coup. Environmental claims proved conditional at best. Billions in subsidies flowed to failing companies. Taxpayers absorbed losses while corporations extracted rents and walked away. It worked well for the corporations, but the coup failed Canadians and Canadian workers. They are not building back better.
Green ideology provided perfect cover for this overreach. Invoke climate emergency, and fiscal responsibility vanishes. Question subsidies and you’re labelled a denier. Point out that environmental benefits depend on specific conditions, and you’re accused of spreading misinformation. The rhetorical shield, aided and abetted by a complicit media unable to see past its own financial interests, allowed government to bypass scrutiny that should attend any massive industrial policy intervention.
The Trust Deficit
As Canadians learn that EV environmental benefits depend heavily on electricity sources and driving patterns, as they watch subsidized companies collapse, as they discover how thoroughly the promise was oversold and how completely Ottawa ignored contrary evidence, trust in government erodes. This badly needed skepticism will spread beyond EVs and undermine legitimate government functions.
It would be good if future government claims about environmental policy face rising skepticism. Corporations wrapping themselves in green rhetoric may be viewed as con artists. Environmental activists who championed these policies may see their credibility destroyed. When citizens conclude their government systematically misled them about costs, benefits, and basic facts while suppressing inconvenient research, liberal democracy itself suffers. But that may not happen at all in Laurentian LaLa-land or in the Pacific Lotusland.
Over fifty billion dollars are distributed among local and foreign industrialists, while tens of thousands live in tents in Laurentian cities.
The EV debacle demonstrates that overselling policy benefits, suppressing complexity, and using ideology to short-circuit debate produce a backlash far worse than honest acknowledgment of nuance would have. The damage compounds when governments commit billions based on conditional environmental claims they never verified, then remain silent when industry-leading manufacturers publish data revealing those conditions.
The Path Forward
Canada needs a full repeal of the EV mandate and a complete retreat from Ottawa directing market decisions. The EV law must be struck, not merely paused. The 2030 and 2035 targets must be abandoned entirely. No new subsidies for EV production (or any other production). No bailouts for failed battery plants. No additional funds for charging infrastructure. And absolutely no subsidies for conventional or hybrid vehicle production justified by the same environmental complexity that should have prevented EV mandates in the first place.
Let markets determine which technologies Canadians choose. If EVs deliver genuine value for specific consumers in specific circumstances—those with clean electricity grids, high annual mileage, and long vehicle ownership timelines—those consumers will buy them without mandates or subsidies. If hybrids or improved conventional vehicles better serve other consumers’ needs, manufacturers will produce them without government direction.
The aggregated wisdom of millions of economic actors making decisions based on their actual circumstances will produce better outcomes than any planning committee in Ottawa. Some Canadians will find EVs deliver environmental and financial benefits. Others will not. Both conclusions can be correct simultaneously, a nuance Ottawa spent $50 billion refusing to acknowledge.
Markets work because no one has to know everything. Central planning fails because someone must. I wish I could say that Ottawa has learned this lesson the expensive way. Or whether Laurentians will remember it at the next election. Or whether the same politicians and bureaucrats who delivered this disaster will identify the next technology to mandate and subsidize, armed with new promises that reality will eventually expose as conditional at best.
But let’s keep our dreams in check. It seems more likely, given their ideological make-up and propensities for certainty, that low-information Laurentian and Pacific Coast voters will go right for the next green-washed fantasy that the feds and provincial governments will put in front of them, provided it is coiled into a catchy slogan.
Subscribe to Haultain Research.
For the full experience, and to help us bring you more quality research and commentary,
please upgrade your subscription.
-
Business2 days agoCanada invests $34 million in Chinese drones now considered to be ‘high security risks’
-
Great Reset2 days agoSurgery Denied. Death Approved.
-
Business2 days agoThe Climate-Risk Industrial Complex and the Manufactured Insurance Crisis
-
Crime1 day agoInside the Fortified Sinaloa-Linked Compound Canada Still Can’t Seize After 12 Years of Legal War
-
Health2 days agoThe Data That Doesn’t Exist
-
Economy2 days agoAffordable housing out of reach everywhere in Canada
-
Automotive4 hours agoThe $50 Billion Question: EVs Never Delivered What Ottawa Promised
-
National1 day agoLiberal bill “targets Christians” by removing religious exemption in hate-speech law




